STAT3 and hepatocellular carcinoma: Signal transducer and activator of transcription 3 (STAT3) overexpression serves as a poor prognostic factor and functionally plays a positive role in promoting HCC progression by critical molecular events, including acquisition of EMT phenotype and increased expression levels of matrix metalloproteinase (MMP)-2 and -9 [73].